OR WAIT null SECS
DataLabs, an innovative developer of Internet-based applications for clinical development, announced today that it has signed a technology development and preferred provider agreement with United BioSource Corporation (UBC), which provides science- and evidence-based services and information to the biopharmaceutical industry.
Irvine , Calif. -- June 13, 2005 -- DataLabs, an innovative developer of Internet-based applications for clinical development, announced today that it has signed a technology development and preferred provider agreement with United BioSource Corporation (UBC), which provides science- and evidence-based services and information to the biopharmaceutical industry. UBC and DataLabs are working together to deliver electronic data capture solutions specific for late stage clinical trials.
"UBC selected DataLabs based upon the advanced technology and open architecture of their software," said Chad Clark, Senior Vice President of Operations for United BioSource Corp. "UBC is focused on helping pharmaceutical companies provide scientific evidence to support the use of their products. DataLabs technology will help us deliver the high-quality evidence-based product development solutions that our clients have come to expect from UBC."
UBC is a global company focused on meeting the growing demand for evidence to support the use of pharmaceuticals, biologics, medical devices, and diagnostic technology. UBC's evidence-based product support provides clients in the biopharmaceutical, medical device, and diagnostics industries with the rigorous, scientific evidence necessary to demonstrate the effectiveness, safety, and economic value of their products.
"DataLabs is pleased to have been selected by UBC," said Jim Langford, president of DataLabs. "As a leader in providing late stage services to the biopharmaceutical industry, we believe our collaboration with UBC will greatly improve our capabilities in this rapidly expanding market segment."
DataLabs allows contract research organizations, biotech, pharmaceutical companies, and academic institutions to accelerate clinical trials with the DataLabsXC suite of software for clinical study design, electronic data capture and data management. Unlike traditional application service provider (ASP) models, DataLabsXC offers organizations the flexibility to adapt the software to unique specifications and conduct studies in a cost-effective manner. DataLabsXC, based on Microsoft platform technology, XML Web services, and the CDISC ODM standard, easily adapts to each institution's complex operating procedures and integrates easily with their existing technology systems.
About United BioSource Corporation
United BioSource Corporation (UBC) delivers evidence-based solutions to optimize the medical and commercial potential of pharmaceuticals, biotechnology, medical devices, and diagnostics. UBC is based in Bethesda, Maryland. For more information about UBC, visit www.unitedbiosource.com or call 240-644-0420.
DataLabs is an innovative developer of Internet-based applications for clinical development that helps the biopharmaceutical industry accelerate clinical trials with proven software for study design, data capture and data management. Based on Microsoft platform technology, XML Web services and CDISC ODM standards, the DataLabsXC product suite adapts to established operating procedures and integrates easily with existing technology systems. As a result, DataLabsXC customers enjoy a low total cost of ownership and high return on investment. Major pharmaceutical companies, government entities, healthcare organizations and contract research organizations are currently realizing time and cost savings using DataLabsXC. DataLabs is based in Irvine, Calif. with East Coast offices in North Wales, Pa. For more information, please visit www.datalabs.com.